Zirconium ammonium fluoride

  • Ammonium fluozirconate
  • Ammonium hexafluorozirconate
Formula
(NH4)2ZrF6
Structure
Description
Rhombic, hexagonal crystals.
Uses
Medication.

Registry Numbers and Inventories.
CAS
16919-31-6
EC (EINECS/ELINCS)
240-970-4
Beilstein/Gmelin
42184 (G)
Canada DSL/NDSL
DSL
US TSCA
Listed
Austrailia AICS
Listed
New Zealand
Listed
Japan ENCS (MITI)
Listed
Korea ECL
Listed

Properties.
Formula
F6H8N2Zr
Formula mass
241.28
Density
1.154 g/cm3 (20 C)
Solubility in water
soluble

Hazards and Protection.
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Small spills/leaks
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability
No data.
Incompatibilities
Strong oxidizing agents.

Fire.
Fire fighting
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.

Health.
Exposure limit(s)
IDHL: 500 mg/m3
Exposure effects
Hyperactive reflexes, painful muscle spasms, weakness and tetanic contractures may be noted due to fluoride induced hypocalcemia. Prenatal fluoride supplementation (2.2 mg NaF or 1 mg fluoride daily) during the last two trimesters of pregnancy has been reported to be safe.
   Ingestion
Epigastric pain, nausea, dysphagia, salivation, hematemesis, and diarrhea may be noted. These effects may be delayed for several hours following exposure. Gi symptoms are noted when 3 to 5 mg/kg of fluoride are ingested.
   Inhalation
Respirations are first stimulated then depressed. Death is usually from respiratory paralysis. Following inhalation, coughing and choking may be noted.
   Skin
Urticaria and pruritus have been reported following exposure to fluoride.

First aid
 
   Ingestion
Administer milk, calcium gluconate, or calcium lactate to bind fluoride ion in the gastrointestinal tract. Antacids (aluminum and/or magnesium based) should be administered. Iv calcium (gluconate or chloride) and magnesium may be necessary to correct serum deficits of these divalent metals in serious overdosage. Monitor ekg and vital signs.
   Inhalation
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
   Skin
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
   Eyes
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.

Transport.